The overall annual incidence of venous thromboembolism (VTE) in the United States is estimated to be 1 - 2 per 1000 of the population, with mortality rates ranging between 10% and 30% within 30 days.8 However, the prevalence of COVID-19 associated PE may be as high as 37.1% (Table 1).